Skip to main content
Premium Trial:

Request an Annual Quote

EC Gives European Consortium $16M to Study How RNAi Can Help Rx Development

NEW YORK (GenomeWeb News) — A UK research institute will lead an €11.8-million ($16-million) research consortium that will study the potential uses for RNA interference in treating disease.
 
The Sainsbury Institute at the John Innes Center in Norwich said the European Commission-funded consortium will comprise 17 labs in nine European countries. The group will be called Silencing RNAs: Organizers and Coordinators of Complexity in Eukaryotic Organisms.
 
Researchers involved in the programs will study the uses of RNAi in plant and animal systems, including humans.
 
The Institute said it will use model systems that will allow scientists to conduct experiments it could not perform in humans, but that could translate into therapeutics.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.